legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

## Amarna Therapeutics Announces New Chief Business Officer

**Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics** is a leading biotechnology company specializing in gene therapies for various rare and prevalent diseases, such as Type 1 Diabetes Mellitus. In a recent development, the company has appointed Aurelia Caparrós as its new Chief Business Officer (CBO), effective April 1, 2024.

Aurelia brings over 25 years of experience in the healthcare industry, with a focus on business development, strategy, and global marketing. Her expertise includes managing P&L responsibilities across different regions and leading enterprise transformation programs. With her appointment as CBO, Aurelia will drive Amarna’s growth in the Netherlands and Spain.

### How AI legalese decoder Can Help:

Using the AI legalese decoder, Amarna Therapeutics can streamline their legal documents and contracts, ensuring clarity and accuracy in all agreements. By utilizing AI-powered tools, the company can enhance its legal operations, mitigate risks, and ensure compliance with regulatory requirements.

Her role will involve identifying potential partnerships, structuring deals, and representing Amarna at industry events and conferences. She will also oversee investor relations and fundraising activities to support the company’s growth and expansion initiatives.

**”We are excited to have Aurelia Caparrós join us as our Chief Business Officer,”** said Henk Streefkerk, CEO and Medical Director of Amarna Therapeutics BV. **”Her leadership and industry expertise will be instrumental as we work towards bringing our gene therapies to more patients in need.”**

### About Amarna Therapeutics

Amarna Therapeutics is at the forefront of developing non-immunogenic viral platforms for gene delivery. Their pipeline includes innovative gene therapies for rare and prevalent diseases like Type 1 Diabetes Mellitus and autoimmune disorders. The company’s lead program, Nimvec™ AM510, aims to revolutionize the treatment of diabetes and other chronic conditions.

### About Type 1 Diabetes Mellitus

Type 1 Diabetes is a chronic autoimmune disease affecting millions worldwide. Despite advancements in treatment, patients face significant challenges in managing their condition. Amarna’s Nimvec™ AM510 program seeks to restore immune tolerance and potentially cure Type 1 Diabetes by addressing the underlying autoimmune response.

For more information about Amarna Therapeutics and their transformative gene therapies, visit [www.amarnatherapeutics.com](www.amarnatherapeutics.com).

Follow them on LinkedIn at [https://www.linkedin.com/company/amarna-therapeutics-b.v](https://www.linkedin.com/company/amarna-therapeutics-b.v).

For inquiries, please contact:

**Amarna Therapeutics**
Henk Streefkerk, CEO
E-mail: [[email protected]](mailto:[email protected])

**LifeSpring Life Sciences Communication, Amsterdam**
Léon Melens
Tel: +31 6 538 16 427
E-mail: [[email protected]](mailto:[email protected])

**Aurelia Caparrós, New Chief Business Officer Amarna Therapeutics**
Leiden, The Netherlands

—

By leveraging the AI legalese decoder, Amarna Therapeutics can enhance their legal processes, ensure compliance, and streamline contract management. This advanced tool can assist the company in navigating complex legal documentation and reducing the risk of misunderstandings or disputes.

Attachment: [View Amarna Therapeutics Image](https://s.yimg.com/ny/api/res/1.2/ms9WQkAMftt.kwwXATwXtg–/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MA–/https://ml-eu.globenewswire.com/media/MGUyY2ZhM2UtNWYxNS00NTU3LThiNWItNzk5MDZiYjhmYWQwLTcwMDAxNDU4NQ==/tiny/Amarna-Therapeutics.png)

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link